News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nymox Pharmaceutical (NYMX) NX-1207 Symposium May 5 in San Diego at Annual Meeting of American Urological Association at San Diego Convention Center


4/30/2013 2:31:41 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HASBROUCK HEIGHTS, N.J., April 30, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce further information about the upcoming Symposium on NX-1207 to be held on May 5 at 3 p.m. in San Diego at the Annual Meeting of the American Urological Association at the San Diego Convention Center. The symposium is entitled, "Clinical studies of NX-1207: Phase 3 Injectable for BPH (Phase 2 for Prostate Cancer)," and will be held at the ICU Theater, Science and Convention Hall #2233 at the Convention Center.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES